Xuping Xie

22.1k total citations · 7 hit papers
132 papers, 7.8k citations indexed

About

Xuping Xie is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Xuping Xie has authored 132 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Infectious Diseases, 63 papers in Public Health, Environmental and Occupational Health and 19 papers in Epidemiology. Recurrent topics in Xuping Xie's work include Mosquito-borne diseases and control (63 papers), SARS-CoV-2 and COVID-19 Research (52 papers) and Viral Infections and Vectors (42 papers). Xuping Xie is often cited by papers focused on Mosquito-borne diseases and control (63 papers), SARS-CoV-2 and COVID-19 Research (52 papers) and Viral Infections and Vectors (42 papers). Xuping Xie collaborates with scholars based in United States, China and Singapore. Xuping Xie's co-authors include Pei‐Yong Shi, Jing Zou, Hongjie Xia, Vineet D. Menachery, Scott C. Weaver, Xianwen Zhang, Antonio E. Muruato, Chao Shan, Ping Ren and Zhiming Yuan and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Xuping Xie

126 papers receiving 7.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evasion of Type I Interferon by SARS-CoV-2

2020 655 citations Hongjie Xia, Xuping Xie et al. profile →
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

2021 383 citations Xuping Xie, Yang Liu et al. Nature Medicine profile →
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission

2021 341 citations Yang Liu, Jianying Liu et al. Nature profile →
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster

2022 251 citations Chaitanya Kurhade, Jing Zou et al. Nature Medicine profile →
An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction

2018 227 citations Hongjie Xia, Huanle Luo et al. Nature Communications profile →
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

2022 223 citations Yang Liu, Jianying Liu et al. profile →
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

2021 212 citations Jianying Liu, Yang Liu et al. Nature profile →

Peers

Countries citing papers authored by Xuping Xie

Since Specialization

Citations

This map shows the geographic impact of Xuping Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuping Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuping Xie more than expected).

Fields of papers citing papers by Xuping Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuping Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuping Xie. The network helps show where Xuping Xie may publish in the future.

Co-authorship network of co-authors of Xuping Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xuping Xie. A scholar is included among the top collaborators of Xuping Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuping Xie. Xuping Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3 2025 ·mBio ·Yanping Hu, Jing Zou, (unknown), (unknown), Jason Yeung, Haiping Hao, Pei‐Yong Shi, Ping Ren, Xuping Xie	2
2	A dual-reporter HCoV-OC43 for coronavirus biology and countermeasure development 2025 ·Antiviral Research ·(unknown), Jing Zou, (unknown), Ping Ren, Pei‐Yong Shi, Vineet D. Menachery, Xuping Xie	0
3	A multichannel graph neural network based on multisimilarity modality hypergraph contrastive learning for predicting unknown types of cancer biomarkers 2024 ·Briefings in Bioinformatics ·Xinfei Wang, Lan Huang, Yan Wang, Renchu Guan, Zhu‐Hong You, Nan Sheng, Xuping Xie, Qixing Yang	5
4	Structure and inhibition of SARS-CoV-2 spike refolding in membranes 2024 ·Science ·Michael W. Grunst, Zhuan Qin, (unknown), Shilei Ding, Jérémie Prévost, Yaozong Chen, Yanping Hu, Marzena Pazgier, Shenping Wu, Xuping Xie, Andrés Finzi, José N. Onuchic, Paul C. Whitford, Walther Mothes, Wenwei Li	20
5	Metformin restrains ZIKV replication and alleviates virus-induced inflammatory responses in microglia 2023 ·International Immunopharmacology ·Xiaofang Wang, Hui Wang, Panpan Yi, (unknown), G A Casey, Xuping Xie, Huanle Luo, Jiyang Cai, Xuegong Fan, Lynn Soong, Haitao Hu, Pei‐Yong Shi, Yuejin Liang, Jiaren Sun	5
6	An Integrated Research–Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay 2023 ·Viruses ·Jing Zou, Chaitanya Kurhade, (unknown), Yanping Hu, (unknown), David L. Beaver, (unknown), (unknown), (unknown), (unknown), Peter McCaffrey, (unknown), Pei‐Yong Shi, Ping Ren, Xuping Xie	3
7	A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity 2023 ·npj Vaccines ·Awadalkareem Adam, Birte Kalveram, (unknown), Jason Yeung, (unknown), Ankita Singh, Pei‐Yong Shi, Xuping Xie, Tian Wang	5
8	Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster breakdown → 2022 ·Nature Medicine ·Chaitanya Kurhade, Jing Zou, Hongjie Xia, Mingru Liu, (unknown), Ping Ren, Xuping Xie, Pei‐Yong Shi	251
9	Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine 2022 ·Nature Communications ·Chaitanya Kurhade, Jing Zou, Hongjie Xia, Hui Cai, Qi Yang, Mark Cutler, David Cooper, Alexander Muik, Kathrin U. Jansen, Xuping Xie, Kena A. Swanson, Pei‐Yong Shi	41
10	Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections 2022 ·mBio ·Jing Zou, Xuping Xie, Mingru Liu, Pei‐Yong Shi, Ping Ren	7
11	Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2 2022 ·Nature Communications ·Jing Zou, Chaitanya Kurhade, Hongjie Xia, Mingru Liu, Xuping Xie, Ping Ren, Pei‐Yong Shi	22
12	Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera breakdown → 2021 ·Nature Medicine ·Xuping Xie, Yang Liu, Jianying Liu, Xianwen Zhang, Jing Zou, Camila R. Fontes-Garfias, Hongjie Xia, Kena A. Swanson, Mark Cutler, David Cooper, Vineet D. Menachery, Scott C. Weaver, Philip R. Dormitzer, Pei‐Yong Shi	383
13	Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 2021 ·Nature Communications ·Xuping Xie, Antonio E. Muruato, Xianwen Zhang, Kumari G. Lokugamage, Camila R. Fontes-Garfias, Jing Zou, Jianying Liu, Ping Ren, Mini Balakrishnan, Tomáš Cihlář, Chien‐Te K. Tseng, Shinji Makino, Vineet D. Menachery, John P. Bilello, Pei‐Yong Shi	0
14	BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants breakdown → 2021 ·Nature ·Jianying Liu, Yang Liu, Hongjie Xia, Jing Zou, Scott C. Weaver, Kena A. Swanson, Hui Cai, Mark Cutler, David Cooper, Alexander Muik, Kathrin U. Jansen, Uğur Şahin, Xuping Xie, Philip R. Dormitzer, Pei‐Yong Shi	212
15	Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease 2021 ·Cell Host & Microbe ·James Brett Case, Rita E. Chen, Longxing Cao, Baoling Ying, Emma S. Winkler, Max Johnson, Inna Goreshnik, Minh N. Pham, Swathi Shrihari, Natasha M. Kafai, Adam L. Bailey, Xuping Xie, Pei‐Yong Shi, Rashmi Ravichandran, Lauren Carter, Lance Stewart, David Baker, Michael Diamond	40
16	The N501Y spike substitution enhances SARS-CoV-2 infection and transmission breakdown → 2021 ·Nature ·Yang Liu, Jianying Liu, Kenneth S. Plante, Jessica A. Plante, Xuping Xie, Xianwen Zhang, Zhiqiang Ku, Zhiqiang An, Dionna Scharton, Craig Schindewolf, Steven G. Widen, Vineet D. Menachery, Pei‐Yong Shi, Scott C. Weaver	341
17	Engineering SARS-CoV-2 using a reverse genetic system 2021 ·Nature Protocols ·Xuping Xie, Kumari G. Lokugamage, Xianwen Zhang, Michelle N. Vu, Antonio E. Muruato, Vineet D. Menachery, Pei‐Yong Shi	106
18	Inhibition of innate immune response ameliorates Zika virus-induced neurogenesis deficit in human neural stem cells 2021 ·PLoS neglected tropical diseases ·Pei Xu, Junling Gao, Chao Shan, Tiffany Dunn, Xuping Xie, Hongjie Xia, Jing Zou, (unknown), (unknown), Yongjia Yu, Alexander N. Freiberg, Nikos Vasilakis, Pei‐Yong Shi, Scott C. Weaver, Ping Wu	8
19	Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses 2020 ·Antiviral Research ·K. Reddisiva Prasanth, Minato Hirano, W. Samuel Fagg, Eileen T. McAnarney, Chao Shan, Xuping Xie, Adam Hage, Colette Pietzsch, Alexander Bukreyev, Ricardo Rajsbaum, Pei‐Yong Shi, Mark T. Bedford, Shelton S. Bradrick, Vineet D. Menachery, Mariano A. García-Blanco	20
20	Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach 2018 ·Journal of Virology ·Chao Shan, Xuping Xie, Jing Zou, Roland Züst, Bo Zhang, Rebecca L Ambrose, Jason M. Mackenzie, Katja Fink, Pei‐Yong Shi	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact